Concepedia

Lugui Qiu

LQ

113

Publications

6.7K

Citations

39

H-Index

1999

Active since

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Dana-Farber Cancer Institute

Central South University

Peking University

Lugui Qiu is an author at Institute of Hematology & Blood Diseases Hospital specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

1999–2024

113

Publications

113

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon et al. · The Lancet Oncology · 2014 · 781 citations

, , +9

Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri et al. · New England Journal of Medicine · 2014 · 780 citations · Full text

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen et al. · New England Journal of Medicine · 2022 · 414 citations · Full text

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Yu‐Tzu Tai, Chirag Acharya, Gang An et al. · Blood · 2016 · 347 citations · Full text

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

Thierry Façon, Meletios Α. Dimopoulos, Angela Dispenzieri et al. · Blood · 2017 · 267 citations · Full text

Rows per page

1–5 of 113